title: [Long-term side effects of chemotherapy for testicular cancer].
abstract: Since the advent of cisplatin-based chemotherapy in the 1970s, a majority of metastatic testicular cancer patients have been cured with chemotherapy and surgery. The high curability of testicular cancer, along with the young age of afflicted patients, can result in patients living for many years after the chemotherapy. Thus, the assessment of late effects of chemotherapy is clinically important in testicular cancer patients. This article summarizes the literature regarding the long-term side effects, and reviews approaches to the amelioration of these side effects.
authors.affiliation: Dept. of Urology, Institute of Clinical Medicine, University of Tsukuba.
authors.forename: Koji
authors.initials: K
authors.lastname: Kawai
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D002945:Cisplatin / Q000009:adverse effects*; D005500:Follow-Up Studies; D018237:Germinoma / Q000097:blood / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D008297:Male; D009845:Oligospermia / Q000139:chemically induced; D010984:Platinum / Q000097:blood; D013736:Testicular Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000532:radiotherapy; D013737:Testis / Q000503:physiopathology
chemical_list: D000970:Antineoplastic Agents; D010984:Platinum; D002945:Cisplatin